Sunday, October 11, 2026

Air Products to Deconsolidate $8.4B NEOM Green Hydrogen Project in June 2027

Air Products expects to deconsolidate its NEOM green hydrogen joint venture from its balance sheet when the facility becomes operational in June 2027. The move will remove billions in project debt and assets from Air Products' consolidated financials while maintaining the company's 33.3% equity stake in the world's largest green hydrogen plant.

Air Products to Deconsolidate $8.4B NEOM Green Hydrogen Project in June 2027
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.
Loading stream...

Air Products will deconsolidate the NEOM green hydrogen joint venture from its balance sheet when the Saudi Arabian facility begins operations in June 2027. The accounting change will remove the multi-billion dollar project from the company's consolidated debt and assets.

Air Products holds a 33.3% stake in the joint venture alongside ACWA Power and Saudi Arabia's NEOM. The project represents the world's largest green hydrogen production facility, designed to produce 650 tons of hydrogen daily using 4 gigawatts of renewable power from solar and wind.

Deconsolidation occurs when a parent company loses control of a subsidiary or joint venture. Air Products will shift from consolidating 100% of the project's assets and liabilities to reporting only its proportionate equity investment. This typically improves debt-to-equity ratios and other balance sheet metrics.

The NEOM facility has carried a total project cost estimated at $8.4 billion. Air Products has funded its share of construction through a combination of equity contributions and project finance debt. Once operational, the plant will convert hydrogen into ammonia for global export to markets in Asia, Europe and North America.

Air Products reported Q1 2025 earnings with total debt of $16.2 billion. The deconsolidation will remove the NEOM project debt from this total, though the company retains obligations related to its ownership percentage. The accounting treatment reflects the joint venture structure where no single partner controls operations.

The facility uses thyssenkrupp nucera electrolyzers and Haldor Topsoe technology. Air Products will be the exclusive off-taker of the green ammonia under a 30-year agreement, distributing the product through its global network. The company plans to reconvert ammonia back to hydrogen at end-use markets.

Investors monitoring Air Products' leverage metrics should note the June 2027 deconsolidation date. The balance sheet change does not alter cash flows or the economic value of the company's stake, but will materially impact reported financial ratios used in debt covenants and credit analysis.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleYahoo Finance· January 30, 2026
    Air Products and Chemicals Q1 Earnings Call Highlights
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Agentic AI Rewires Enterprise Software: Platform Incumbents, Governance, and a Funded Startup Wave
Enterprise software is being rebuilt around autonomous AI agents. Incumbents and large platforms (SAP with its Autonomous Suite and Joule, Zeta with AthenaOS/AIM/Athena MCP, Meta with its new Enterprise Platform) are racing to own the agent layer. Meanwhile, seed and Series A money flows to finance-office and vertical startups (Dextr, Latitude, Dentira, Light), and consolidation continues through acquisitions (Tiny–Oso Cloud, Harvey–Guardrails AI). Investor commentary stresses that AI is better at disrupting around the edges of systems of record than at replacing them, that it should not be trusted with finance calculations, and that governance must be enforced by the system rather than left to agents.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,369 source documents archived
Query this data → isubstrate.com